Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: The Gambler who wrote (256)	11/9/1998 10:07:00 AM
From: Mac S. Giballa	Read Replies (1) \| Respond to of 318

Although these were primate studies, the results are huge. Arterial and aortic stiffness are a major pathologic part of aging, and contribute to systolic hypertension and other problems. This finding is potentially huge. I was considering selling 40% of my ALTN stock this am, because I'm expecting negative results from ACTION 1, but this news has kept me hooked. If I have to hold another 3 years to get some human results with our AGE-breaker, than I'll hold, I think its huge.